Enbumyst FDA Approval History
FDA Approved: Yes (First approved September 12, 2025)
Brand name: Enbumyst
Generic name: bumetanide
Dosage form: Nasal Spray
Company: Corstasis Therapeutics Inc.
Enbumyst (bumetanide) nasal spray is a loop diuretic indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including nephrotic syndrome in adults.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.